Rothschild & Co Asset Management US’s Usana Health Sciences USNA Stock Holding History

Rothschild & Co Asset Management US’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-29,112	Closed	-$1.87M	–	549
2017 Q2	$1.87M	Buy	29,112 +298	+1%	+$18.4K	0.02%	327
2017 Q1	$1.66M	Sell	28,814 -120	-0.4%	-$7.16K	0.02%	337
2016 Q4	$1.77M	Buy	28,934 +25,090	+653%	+$1.63M	0.02%	345
2016 Q3	$266K	Buy	+3,844	New	+$254K	﹤0.01%	519

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rothschild & Co Asset Management US's USNA Position: Q3 2017 in Review

Rothschild & Co Asset Management US sold out of Usana Health Sciences (USNA) in Q3 2017, closing a stake of 29,112 shares — an estimated $1.87M sold.

Rothschild & Co Asset Management US first reported a position in USNA in Q3 2016 and held it in 4 quarters. The position peaked at $1.87M in Q2 2017. 144 funds tracked by Wall St. Rank hold USNA as of Q3 2017.

Rothschild & Co Asset Management US reported no remaining Usana Health Sciences position as of Q3 2017 after selling out during the quarter.
Rothschild & Co Asset Management US sold 29,112 Usana Health Sciences shares in Q3 2017, an estimated $1.87M.
Rothschild & Co Asset Management US first reported a position in Usana Health Sciences in Q3 2016 and held it in 4 quarters.
Rothschild & Co Asset Management US's Usana Health Sciences position peaked at $1.87M in Q2 2017.
144 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2017, filed 8 Nov 2017.